Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-04-12
1995-11-07
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530331, A61K 3800, C07K 500, C07K 700, C07K 1700
Patent
active
054648254
ABSTRACT:
The preparation and use of N-acyl glutathione monoalkyl esters to provide increased intracellular levels of glutathione or glutathione equivalents, e.g. N-acyl glutathione or glutathione monoalkyl esters.
REFERENCES:
patent: 2209299 (1940-07-01), Schoeller et al.
patent: 2760956 (1956-08-01), Brick
patent: 2938023 (1960-05-01), Weygand et al.
patent: 3882097 (1975-05-01), Pfister, III et al.
patent: 3950387 (1976-04-01), Joulie et al.
patent: 3984569 (1976-10-01), Kalopissis et al.
patent: 4643990 (1987-02-01), Umehara et al.
patent: 4709013 (1987-11-01), Nagano
patent: 4710480 (1987-12-01), Meister
patent: 4710489 (1987-12-01), Meister
patent: 4784685 (1988-11-01), Meister
patent: 4879370 (1989-11-01), Meister
patent: 4927808 (1990-05-01), Kitahara et al.
patent: 4968671 (1990-11-01), Asano et al.
Meister, Metabolism & Function of Glutathione, Chapter 11, Coenzymes & Cofactors, vol. III, (1989).
Kalebic et al., Proc. Natl. Acad. Sci. USA, 88:986-990 (1991).
1991 FASEB Abstract, 1 page.
Anderson Mary
Levy Ellen J.
Meister Alton
Cornell Research Foundation Inc.
Huff Sheela J.
Warden Jill
LandOfFree
Raising glutathione equivalent levels using N-acyl glutathione m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Raising glutathione equivalent levels using N-acyl glutathione m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Raising glutathione equivalent levels using N-acyl glutathione m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-197321